iSPERSE shows superiority in multi-drug inhaled dose delivery
In vitro studies on iSPERSE, a cationic salt formulation, have shown delivery of consistent doses, which can have relevance to patients with lower or impaired lung function. iSPERSE
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
Genedata Biologics advances end-to-end biologics R&D activities including antibody screening, protein engineering, and biologics production. The version 2.0 provides new protein production modules supporting production process, including molecule
TRO40303 causes prevention of stress-induced mitochondrial permeability transition, a target implicated in cardiac reperfusion injury. The placebo-controlled, phase II proof-of-concept study in acute MI patients with large myocardial